ImmuOne
A biotech company that has developed a 3D human lung model to replace animal testing
ImmuOne has raised €2.9M across 2 funding rounds from 5 investors, most recently a round in Mar 2025. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKimmuone.com ↗
Total raised
€2.9M
€2,916,178
Funding rounds
2
Investors
5
distinct backers
Active since
2023-10
latest 2025-03
Funding by year
EUR raised per yearImmuOne — funding by year — interactive chart.
Data table
| ImmuOne — funding by year | |
|---|---|
| 2023 | €2.2M |
| 2025 | €716k |
Signals
High confidenceRaise-next likelihood32
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-03-13 | Other | €716k | Mercia Ventures,Midlands Engine Investment Fund,Pioneer Fund | View deal → |
| 2023-10-26 | Other | €2.2M | EIS funds,MEIF Proof of Concept & Early Stage Fund,Pioneer Fund | View deal → |